CHRONIC HEMODYNAMIC-EFFECTS OF CARVEDILOL IN ESSENTIAL-HYPERTENSION AT REST AND DURING EXERCISE

被引:11
|
作者
LUNDJOHANSEN, P
OMVIK, P
机构
[1] Section of Cardiology, Medical Department, University of Bergen, School of Medicine, Haukeland Hospital
关键词
HYPERTENSION; HEMODYNAMICS; CARDIAC OUTPUT; EXERCISE; BETA-BLOCKERS; CARVEDILOL;
D O I
10.1093/oxfordjournals.eurheartj.a060160
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Nineteen men (mean age 44 years) with essential hypertension, WHO stage I, were studied invasively at rest and during exercise. Blood pressure was recorded in intra-arterially (brachial artery), cardiac output by dye dilution method and heart rate by electrocardiography. After initial pre-drug recordings, the patients received 25 mg carvedilol orally and central haemodynamics at rest and during exercise were recorded 1 and 2 h after tablet in take to evaluate the immediate effects of curvedilol. The results indicated a combined β-blocking and vasodilating effect. After 6-9 months of treatment, supine haemodynamics were recorded 12-24 h after the last dose and then 1 and 2 h after an additional 25 mg dose. During chronic treatment (2 h after last dose at rest supine) mean arterial pressure was reduced by 17% (P <0.001) and total peripheral resistance index by 6% (NS) while heart rate and cardiac index were reduced by 12%. Exercise haemodynamics demonstratedafall in bloodpressure of 17% (P <0.001). Exercise stroke index increased by 5% (NS), partly compensatingfor the reduction in heart rate of 17%. Total peripheral resistance index was reduced by 5% (NS). It is concluded that carvedilol is an effective anti-hypertensive agent in a large proportion of patients with essential hypertension. The haemodynamic mode of action reflects an a1-blocking activity, particularly in situations with low sympathetic tone. During exercise the β1-blocking activity (demonstrated by the reduction in heart rate) is more prominent. © 1992 The European Society of Cardiology.
引用
收藏
页码:281 / 286
页数:6
相关论文
共 50 条
  • [31] ACUTE HEMODYNAMIC-EFFECTS OF CARVEDILOL IN COMPARISON WITH PROPRANOLOL IN PATIENTS WITH CORONARY HEART-DISEASE
    WENDT, T
    CLINICAL INVESTIGATOR, 1992, 70 (02): : S93 - S97
  • [32] HEMODYNAMIC-EFFECTS OF CARVEDILOL AFTER ACUTE ORAL-ADMINISTRATION IN HYPERTENSIVE AND NORMAL SUBJECTS
    COURNOT, A
    LIM, C
    DUCHIER, J
    SAFAR, M
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1992, 19 : S35 - S39
  • [33] COMPARISON OF THE HEMODYNAMIC-EFFECTS OF LISINOPRIL AND LISINOPRIL PLUS HYDROCHLOROTHIAZIDE DURING REST AND ORTHOSTATIC STRESS
    WAISMAN, GD
    GALARZA, CR
    ALFIE, J
    MAYORGA, LM
    ARAHABETY, A
    SAGGESE, O
    TESSLER, J
    CAMERA, MI
    DRUG DEVELOPMENT RESEARCH, 1995, : 24 - 29
  • [34] Effects of Acute and Chronic Exercise in Patients With Essential Hypertension: Benefits and Risks
    Gkaliagkousi, Eugenia
    Gavriilaki, Eleni
    Douma, Stella
    AMERICAN JOURNAL OF HYPERTENSION, 2015, 28 (04) : 429 - 439
  • [35] A COMPARATIVE-STUDY OF CARVEDILOL, SLOW-RELEASE NIFEDIPINE, AND ATENOLOL IN THE MANAGEMENT OF ESSENTIAL-HYPERTENSION
    HALL, S
    PRESCOTT, RI
    HALLMAN, RJ
    DIXON, S
    HARVEY, RE
    BALL, SG
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1991, 18 : S35 - S38
  • [36] EFFECTS OF ISRADIPINE ON PERIPHERAL HEMODYNAMIC REFLEX RESPONSES IN MILD-TO-MODERATE ESSENTIAL-HYPERTENSION
    DUPREZ, D
    DEBACKER, T
    DEPUE, N
    HERMANS, L
    DEBUYZERE, M
    CLEMENT, DL
    AMERICAN JOURNAL OF HYPERTENSION, 1991, 4 (02) : S194 - S196
  • [37] PLASMA NEUROPEPTIDE-Y DURING DYNAMIC EXERCISE IN PATIENTS WITH ESSENTIAL-HYPERTENSION
    PRUSZCZYK, P
    CHLEBUS, M
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 1995, 17 (05) : 769 - 785
  • [38] HEMODYNAMIC COMPARISON OF AMLODIPINE AND ATENOLOL IN ESSENTIAL-HYPERTENSION USING THE QUANTASCOPE
    THAM, TCK
    HERITY, N
    GUY, S
    SILKE, B
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 36 (06) : 555 - 560
  • [39] RENAL EFFECTS OF ALACEPRIL IN ESSENTIAL-HYPERTENSION
    TOMITA, K
    NONOGUCHI, H
    TERADA, Y
    MARUMO, F
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1992, 20 (04) : 520 - 524
  • [40] CARDIOVASCULAR EFFECTS OF NISOLDIPINE IN ESSENTIAL-HYPERTENSION
    BLAU, A
    HERZOG, D
    HERZ, I
    BATTLER, A
    SHECHTER, P
    ELIAHOU, HE
    ISRAEL JOURNAL OF MEDICAL SCIENCES, 1994, 30 (02): : 139 - 145